An optimised and effective Contamination Control Strategy (CCS) helps your organisation spend less time cleaning and more time manufacturing.
The experts at Ecolab Life Sciences are dedicated to helping you drive the best possible strategy to meet and exceed the GMP Annex 1* CCS requirements.
*EU GMP Annex 1 Manufacture of Sterile Medicinal Products (2022)
The recent update of Annex 1 has introduced the mandatory requirement for pharmaceutical manufacturers to have a Contamination Control Strategy in place.
As global experts in contamination control, we’re with you every step of the way. Whether you’re in the process of defining, developing or maintaining your CCS, we can work with you to help build a compliant strategy for cleaning, disinfection and bio-decontamination.
We’ve created a guide that details:
Ecolab Life Sciences is trusted around the world for delivering compliant solutions in cleaning, disinfection and bio-decontamination. Our Global Technical Consultants (GTCs) are an international team of Pharmaceutical Microbiologists with decades of industry experience.
Learn more about our world-class GTC services and how they can help your organisation.
We proactively monitor regulatory changes in industry through engagement with relevant bodies such as EP, USP, PDA, CEN, FDA & EPA.
We will work with you to reduce the risks, providing documentation and validation support.
Our experts conduct an in-depth review to help identify, assess and document the risks to your cleanroom contamination control.
Ecolab will support you through the process with a customised end-to-end change management plan.
Annex 1: The Final Version – Impact to Contamination Control with Cleaning, Disinfection and Decontamination
GLOBAL TECHNICAL CONSULTANT REGIONAL LEADERRequest the recording
Contamination Control Strategy For Cleaning and Disinfection – A Case Study
Tim Sandle PhD.
STRATEGIC TECHNICAL CONSULTANT LEAD